ImmunityBio, Inc. (IBRX)
USD 2.73
(8.76%)
USD 2.73
(8.76%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 883.67 Million USD | 22.09% |
| 2022 | 723.77 Million USD | 12.1% |
| 2021 | 645.66 Million USD | 134.32% |
| 2020 | 275.54 Million USD | 1755.79% |
| 2019 | 14.84 Million USD | 114.88% |
| 2018 | 6.91 Million USD | -4.93% |
| 2017 | 7.26 Million USD | -11.47% |
| 2016 | 8.21 Million USD | 232.66% |
| 2015 | 2.46 Million USD | 831.32% |
| 2014 | 265 Thousand USD | -84.94% |
| 2013 | 1.76 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 895.42 Million USD | 1.33% |
| 2024 Q2 | 998.95 Million USD | 11.56% |
| 2023 Q3 | 717.26 Million USD | -12.44% |
| 2023 FY | 883.67 Million USD | 22.09% |
| 2023 Q1 | 766.25 Million USD | 5.87% |
| 2023 Q2 | 819.15 Million USD | 6.9% |
| 2023 Q4 | 883.67 Million USD | 23.2% |
| 2022 Q2 | 664.67 Million USD | 2.45% |
| 2022 Q4 | 723.77 Million USD | 1.66% |
| 2022 Q3 | 711.98 Million USD | 7.12% |
| 2022 FY | 723.77 Million USD | 12.1% |
| 2022 Q1 | 648.79 Million USD | 0.49% |
| 2021 Q4 | 645.66 Million USD | 89.37% |
| 2021 FY | 645.66 Million USD | 134.32% |
| 2021 Q2 | 331.79 Million USD | 4.01% |
| 2021 Q3 | 340.95 Million USD | 2.76% |
| 2021 Q1 | 318.99 Million USD | 15.77% |
| 2020 Q2 | 12.55 Million USD | -8.46% |
| 2020 FY | 275.54 Million USD | 1755.79% |
| 2020 Q4 | 275.54 Million USD | 6.53% |
| 2020 Q3 | 258.66 Million USD | 1960.25% |
| 2020 Q1 | 13.71 Million USD | -92.45% |
| 2019 Q4 | 181.62 Million USD | 1038.19% |
| 2019 Q3 | 15.95 Million USD | 6.4% |
| 2019 Q2 | 14.99 Million USD | -4.93% |
| 2019 Q1 | 15.77 Million USD | 128.29% |
| 2019 FY | 14.84 Million USD | 114.88% |
| 2018 FY | 6.91 Million USD | -4.93% |
| 2018 Q1 | 7.02 Million USD | -3.37% |
| 2018 Q3 | 7.3 Million USD | 6.58% |
| 2018 Q4 | 6.91 Million USD | -5.38% |
| 2018 Q2 | 6.85 Million USD | -2.43% |
| 2017 Q3 | 7.5 Million USD | -66.43% |
| 2017 Q1 | 7.98 Million USD | -2.79% |
| 2017 Q2 | 22.36 Million USD | 180.2% |
| 2017 Q4 | 7.26 Million USD | -3.18% |
| 2017 FY | 7.26 Million USD | -11.47% |
| 2016 Q4 | 8.21 Million USD | 6.58% |
| 2016 Q2 | 2.41 Million USD | -1.39% |
| 2016 Q3 | 7.7 Million USD | 218.7% |
| 2016 FY | 8.21 Million USD | 232.66% |
| 2016 Q1 | 2.45 Million USD | -0.69% |
| 2015 FY | 2.46 Million USD | 831.32% |
| 2015 Q1 | - USD | -100.0% |
| 2015 Q4 | 2.46 Million USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 FY | 265 Thousand USD | -84.94% |
| 2014 Q4 | 265 Thousand USD | 0.0% |
| 2013 FY | 1.76 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Dyadic International, Inc. | 136.92 Thousand USD | -645254.162% |
| Agenus Inc. | 350.24 Million USD | -152.302% |
| AlloVir, Inc. | 27.42 Million USD | -3121.689% |
| Ardelyx, Inc. | 55.98 Million USD | -1478.502% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -4060.634% |
| Chimerix, Inc. | 2.14 Million USD | -41116.278% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -4131.312% |
| CRISPR Therapeutics AG | 238.63 Million USD | -270.31% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -13372.74% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -753.497% |
| Fortress Biotech, Inc. | 88.59 Million USD | -897.468% |
| Fortress Biotech, Inc. | 88.59 Million USD | -897.468% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -16099.395% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -1601779.815% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -559189.241% |
| IO Biotech, Inc. | 2.49 Million USD | -35332.117% |
| Structure Therapeutics Inc. | 5.45 Million USD | -16105.334% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -14233.771% |
| MiMedx Group, Inc. | 48.09 Million USD | -1737.205% |
| Senti Biosciences, Inc. | 37.66 Million USD | -2246.087% |
| Opthea Limited | 200.62 Million USD | -340.454% |
| Pharming Group N.V. | 171.54 Million USD | -415.128% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| PureTech Health plc | 25.51 Million USD | -3363.77% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -1358.718% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2832.2% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -2219.119% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -654.036% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -1323.563% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -874827.723% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -97436.093% |
| PDS Biotechnology Corporation | 23.85 Million USD | -3604.893% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -53947.523% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -1195.144% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -1841.721% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -2651.345% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -285.564% |
| Clearside Biomedical, Inc. | 43 Million USD | -1955.015% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 12.23 Million USD | -7125.487% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -556.989% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -91188.946% |
| Vaxxinity, Inc. | 15.16 Million USD | -5725.93% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -3357.806% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -12480.823% |
| Aptorum Group Limited | 3.36 Million USD | -26181.162% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -14315.612% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -30668.698% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -748.205% |
| ContextLogic Inc. | 6 Million USD | -14627.95% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -771.614% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -1145.036% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -1099985.898% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -4042.689% |
| Royalty Pharma plc | 6.13 Billion USD | 85.597% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -320.516% |
| TG Therapeutics, Inc. | 110.79 Million USD | -697.578% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -2385.362% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -3500.672% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -196023.807% |
| Seer, Inc. | 28.25 Million USD | -3027.064% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -304991.785% |
| NextCure, Inc. | 6.6 Million USD | -13278.91% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -277785.849% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -41582.877% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -535.602% |
| AnaptysBio, Inc. | 17.81 Million USD | -4860.576% |
| ChromaDex Corporation | 3.27 Million USD | -26866.036% |
| Precigen, Inc. | 7.09 Million USD | -12351.416% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -2996.167% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -3115.125% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -53358.984% |
| Acelyrin, Inc. | 1.19 Million USD | -73909.799% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -14134.488% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -11440.175% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -6017.952% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -376781.149% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -6710.088% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -156303.009% |
| AbCellera Biologics Inc. | 77.38 Million USD | -1041.997% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 67.059% |
| Bicycle Therapeutics plc | 44.95 Million USD | -1865.649% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -109211.58% |
| Incyte Corporation | 38.28 Million USD | -2208.034% |
| Alkermes plc | 290.73 Million USD | -203.951% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -52281.565% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 9.88 Million USD | -8838.877% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -8869.519% |
| Geron Corporation | 85.89 Million USD | -928.74% |
| Summit Therapeutics Inc. | 106.09 Million USD | -732.88% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -12828.705% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -5150.606% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -141969.572% |
| Innoviva, Inc. | 449.07 Million USD | -96.777% |
| Jaguar Health, Inc. | 35.86 Million USD | -2364.241% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -185937.263% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -700.737% |
| Vaxcyte, Inc. | 29.22 Million USD | -2923.806% |
| ADMA Biologics, Inc. | 141.41 Million USD | -524.869% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -667.274% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -412833.178% |
| Novavax, Inc. | 280.63 Million USD | -214.885% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -4444.495% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -293759.614% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -50891.171% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -24743.323% |
| Precision BioSciences, Inc. | 31.26 Million USD | -2726.139% |
| GT Biopharma, Inc. | 58 Thousand USD | -1523481.034% |
| ImmuCell Corporation | 11.96 Million USD | -7282.861% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 118.92 Million USD | -643.067% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -3428.78% |
| Aptose Biosciences Inc. | 1 Million USD | -87409.581% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -10208737.8% |
| Soligenix, Inc. | 3.49 Million USD | -25187.211% |
| Century Therapeutics, Inc. | 48.17 Million USD | -1734.458% |
| Kura Oncology, Inc. | 17.2 Million USD | -5037.657% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -856.019% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -41001.256% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -6223.723% |
| Autolus Therapeutics plc | 52.96 Million USD | -1568.354% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -16057.926% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -2011.887% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -285.159% |
| GRI Bio, Inc. | 14 Thousand USD | -6311878.571% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -7012.661% |
| IGM Biosciences, Inc. | 40.5 Million USD | -2081.595% |
| INmune Bio, Inc. | 10.43 Million USD | -8366.772% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -391.948% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -14859.678% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1081776.836% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -106773.485% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -1606.764% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -1416.235% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -1426.951% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -83.777% |
| Verastem, Inc. | 41.55 Million USD | -2026.422% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -16264.389% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -7670.638% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -8905.167% |
| Histogen Inc. | 4.62 Million USD | -19018.931% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -26052.027% |
| Organovo Holdings, Inc. | 1.39 Million USD | -63291.463% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -1820.965% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -16913.419% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -4138902.342% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -944.684% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -422671.505% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -2824.533% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -544314.325% |
| Apollomics, Inc. | 4.66 Million USD | -18858.957% |
| Amarin Corporation plc | 8.73 Million USD | -10014.193% |
| Turnstone Biologics Corp. | 3.21 Million USD | -27394.617% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -943.623% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -357663.968% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -805.342% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -365.23% |
| Better Therapeutics, Inc. | 14.88 Million USD | -5838.69% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -2786.513% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -696.622% |
| NLS Pharmaceutics AG | 1.63 Million USD | -53989.008% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -743.404% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -31618.485% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -1808119.767% |
| Avid Bioservices, Inc. | 207.83 Million USD | -325.184% |
| Insmed Incorporated | 1.2 Billion USD | 26.605% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -13067.591% |
| OmniAb, Inc. | 25.56 Million USD | -3357.13% |
| Alector, Inc. | 38.91 Million USD | -2170.613% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -313.057% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -5732.467% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -84.702% |
| Aura Biosciences, Inc. | 19.55 Million USD | -4418.469% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -1298.954% |
| Immunic, Inc. | 1.33 Million USD | -66142.654% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -2684.813% |
| Veracyte, Inc. | 12.63 Million USD | -6896.651% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -37.033% |
| FibroGen, Inc. | 170.45 Million USD | -418.422% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -9631.054% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -433264.066% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 84.755% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -2388216.216% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -20756.195% |
| Galecto, Inc. | 249 Thousand USD | -354790.361% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -52941.837% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 47.337% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -11977.04% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -16273.485% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -31618.485% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -3187.367% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -1860.546% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -62174.63% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1853.482% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -1947.018% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -1732.252% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | -4.12% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -85911.166% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -7966.426% |
| NexImmune, Inc. | 68.8 Thousand USD | -1284146.247% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -6225608.046% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 67.306% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -225326.656% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -12695.786% |
| Ainos, Inc. | 5.96 Million USD | -14717.954% |
| Pluri Inc. | 29.61 Million USD | -2884.185% |
| Prothena Corporation plc | 11.83 Million USD | -7366.641% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -3401.791% |
| Celularity Inc. | 65.41 Million USD | -1250.837% |
| Rallybio Corporation | 392 Thousand USD | -225327.806% |
| Cue Biopharma, Inc. | 14.69 Million USD | -5913.454% |
| MeiraGTx Holdings plc | 89.26 Million USD | -889.959% |
| Omeros Corporation | 338.28 Million USD | -161.226% |
| Humacyte, Inc. | 58.1 Million USD | -1420.802% |
| Immunocore Holdings plc | 84.03 Million USD | -951.596% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -47588.991% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -18019.274% |
| Blueprint Medicines Corporation | 774.12 Million USD | -14.152% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -17510.143% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -1329.482% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -748.906% |
| Pulmatrix, Inc. | 8.75 Million USD | -9992.245% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -12675.437% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -6280.339% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -666.11% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -2701.055% |
| Cytokinetics, Incorporated | 755.77 Million USD | -16.924% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -6502.488% |
| Nutriband Inc. | 241.28 Thousand USD | -366137.852% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -16063.838% |
| Vor Biopharma Inc. | 35.66 Million USD | -2378.062% |
| Roivant Sciences Ltd. | 499.74 Million USD | -76.824% |
| Evogene Ltd. | 1.13 Million USD | -77551.757% |
| ProKidney Corp. | 4.41 Million USD | -19924.405% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -71978.059% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 49.209% |
| CorMedix Inc. | 667.63 Thousand USD | -132259.893% |
| BioLineRx Ltd. | 11.59 Million USD | -7523.82% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -2170.496% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -1130.628% |
| Atai Life Sciences N.V. | 16.47 Million USD | -5263.42% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -35953.792% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -130815.111% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -1830.564% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -1359403.077% |
| MediciNova, Inc. | 215.92 Thousand USD | -409149.928% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -35317.916% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -69975.922% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -374.147% |
| Biomea Fusion, Inc. | 10.29 Million USD | -8482.721% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -112.921% |
| Mereo BioPharma Group plc | 5.95 Million USD | -14746.724% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -24514.958% |
| Absci Corporation | 15.95 Million USD | -5437.864% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -9546.076% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -5923.291% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -3123.334% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -7108.982% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -6966.024% |
| Allakos Inc. | 41.46 Million USD | -2031.14% |
| Imunon, Inc. | 1.62 Million USD | -54289.696% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -8066.315% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -585116.556% |
| BioAtla, Inc. | 2.46 Million USD | -35821.829% |
| NLS Pharmaceutics AG | 1.63 Million USD | -53989.008% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -781915.044% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -829.003% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -15833.592% |
| XOMA Corporation | 124.45 Million USD | -610.066% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -4567.39% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -1947.112% |
| aTyr Pharma, Inc. | 15.09 Million USD | -5754.104% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -7833.893% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -3293.146% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -4098.389% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -253102.579% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -270557.258% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -54056.001% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 41.059% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -538835.883% |
| UroGen Pharma Ltd. | 100.21 Million USD | -781.79% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -383.547% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -255045.781% |
| Orgenesis Inc. | 22.62 Million USD | -3806.445% |
| Entera Bio Ltd. | 390 Thousand USD | -226483.846% |
| GH Research PLC | 343 Thousand USD | -257531.778% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -289630.164% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -90719.836% |
| Xencor, Inc. | 83.43 Million USD | -959.133% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -511663.275% |
| Replimune Group, Inc. | 75.86 Million USD | -1064.741% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -72082.506% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -9296.821% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -538835.883% |
| Portage Biotech Inc. | 47 Thousand USD | -1880063.83% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -69975.922% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -36460.902% |
| OncoCyte Corporation | 2.86 Million USD | -30700.871% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -67916.173% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -586850.197% |
| Purple Biotech Ltd. | 351 Thousand USD | -251659.829% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -27873.314% |
| scPharmaceuticals Inc. | 40.26 Million USD | -2094.435% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -1626.168% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -622207.746% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -16793.08% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -3204.948% |
| Curis, Inc. | 2.79 Million USD | -31527.666% |
| Daré Bioscience, Inc. | 5.31 Million USD | -16516.264% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -41261.952% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -5181.675% |
| BeiGene, Ltd. | 930.18 Million USD | 5.0% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -5585.553% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -904.818% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -77347.59% |
| Erasca, Inc. | 55.85 Million USD | -1481.978% |
| bluebird bio, Inc. | 330.32 Million USD | -167.517% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 22.066% |
| DBV Technologies S.A. | 14.38 Million USD | -6044.753% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -35218.825% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -18928.359% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -118.308% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -1819.41% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -19072.857% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -34663.061% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -4587.196% |
| MacroGenics, Inc. | 33.97 Million USD | -2501.269% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -4123.27% |
| Prime Medicine, Inc. | 13.63 Million USD | -6381.897% |
| Aditxt, Inc. | 18.21 Million USD | -4750.574% |
| Adagene Inc. | 22.3 Million USD | -3861.457% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -5674.534% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -44.636% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -4254.59% |
| SciSparc Ltd. | 76 Thousand USD | -1162632.895% |
| Vericel Corporation | 88.14 Million USD | -902.549% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -977.434% |
| Generation Bio Co. | 97.89 Million USD | -802.688% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -268494.833% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -3393.071% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -329.144% |
| Invivyd, Inc. | 2.16 Million USD | -40716.49% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -1552.783% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -25077786.217% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -15842.215% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -1402561.905% |
| 2seventy bio, Inc. | 256.67 Million USD | -244.281% |
| Clene Inc. | 32.16 Million USD | -2647.666% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -15645.772% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -40158.633% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -1643.916% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -183523.103% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -357.409% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -2833.27% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -5038.553% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -609.553% |
| Evaxion Biotech A/S | 10.86 Million USD | -8029.743% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -959.705% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -1079.699% |
| Trevena, Inc. | 35.23 Million USD | -2408.095% |
| Surrozen, Inc. | 3.37 Million USD | -26052.027% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -13503.402% |
| Cingulate Inc. | 3.13 Million USD | -28086.574% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -2155209.756% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -3174.09% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -176316.791% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -146446.766% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -1444.755% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -189938.065% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -3025.626% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -4270.528% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -56728.103% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -70033.095% |
| Statera Biopharma, Inc. | 16.26 Million USD | -5334.288% |
| Korro Bio, Inc. | 33.2 Million USD | -2561.117% |
| Kineta, Inc. | 1.31 Million USD | -66997.722% |
| BioVie Inc. | 6.11 Million USD | -14359.374% |
| Codexis, Inc. | 22.36 Million USD | -3851.337% |
| Celularity Inc. | 65.41 Million USD | -1250.837% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -1608.315% |
| Celcuity Inc. | 37.44 Million USD | -2259.852% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -393871.021% |
| Cibus, Inc. | 24.62 Million USD | -3489.119% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -230625.065% |
| IN8bio, Inc. | 4.89 Million USD | -17960.025% |
| Kodiak Sciences Inc. | 181.63 Million USD | -386.521% |
| Annexon, Inc. | 31.35 Million USD | -2718.297% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -1077.671% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -37631.725% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -22540.968% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 39.205% |
| Eyenovia, Inc. | 16.1 Million USD | -5386.033% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -692.607% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -89613.401% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -7612.988% |
| Arcellx, Inc. | 97.62 Million USD | -805.175% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -41020.382% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -3232.995% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -28387.331% |
| Moolec Science SA | 2.64 Million USD | -33305.688% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -3002.036% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -13897.735% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -36689.217% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -766621.329% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -2512.111% |
| Humacyte, Inc. | 58.1 Million USD | -1420.802% |
| 89bio, Inc. | 27.1 Million USD | -3159.838% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -6551.189% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -34980.468% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -65944.619% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -733.155% |
| Notable Labs, Ltd. | 2.04 Million USD | -43027.233% |
| Liquidia Corporation | 3.5 Million USD | -25126.292% |
| Mustang Bio, Inc. | 2.49 Million USD | -35275.38% |
| Immunovant, Inc. | 138 Thousand USD | -640245.652% |
| Quantum-Si incorporated | 15.3 Million USD | -5674.534% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -10032.749% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -220819.25% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -1545.336% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -1081776.836% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -8004.898% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -419720.988% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -435208.867% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -4177.029% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -219174.69% |
| PepGen Inc. | 20.1 Million USD | -4295.528% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -153850.697% |
| United Therapeutics Corporation | 700 Million USD | -26.24% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -3264.466% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -19700.249% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -99637.81% |
| XOMA Corporation | 124.45 Million USD | -610.066% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -322409.854% |
| Bionomics Limited | 239.61 Million USD | -268.786% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -43345.302% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -6556.199% |
| uniQure N.V. | 138.4 Million USD | -538.453% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -934.472% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -85527.616% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -89613.401% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -9631.054% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -50482.541% |
| Altimmune, Inc. | 671 Thousand USD | -131595.529% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -98.553% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -6556.199% |
| Compugen Ltd. | 1.35 Million USD | -65309.104% |
| Peak Bio, Inc. | 10.72 Million USD | -8141.866% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -1966.307% |
| Benitec Biopharma Inc. | 284 Thousand USD | -311053.873% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -945.091% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -4335.907% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -7402.139% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -866.211% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -4335.907% |
| Instil Bio, Inc. | 86.05 Million USD | -926.887% |
| argenx SE | 20 Million USD | -4318.385% |
| Immunome, Inc. | 1.65 Million USD | -53456.182% |
| Verona Pharma plc | 51.32 Million USD | -1621.594% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -8937.4% |
| Shattuck Labs, Inc. | 4.2 Million USD | -20929.914% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -244009.669% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -21035.542% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -150955.897% |
| Moolec Science SA | 2.64 Million USD | -33305.688% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -2825.188% |
| Design Therapeutics, Inc. | 3.05 Million USD | -28873.016% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -337181.298% |
| NeurAxis, Inc. | 224.26 Thousand USD | -393941.291% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -6110.831% |
| Lumos Pharma, Inc. | 6.58 Million USD | -13319.544% |
| Achilles Therapeutics plc | 4.61 Million USD | -19047.931% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -8937.4% |
| 180 Life Sciences Corp. | 1.32 Million USD | -66841.728% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -5073.716% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -56728.103% |
| Nutriband Inc. | 241.28 Thousand USD | -366137.852% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -8552.472% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -106882.688% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -136.454% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -2835.902% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -23796.945% |
| Palisade Bio, Inc. | 369 Thousand USD | -239378.862% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -212834.217% |
| Beam Therapeutics Inc. | 173.17 Million USD | -410.286% |
| Neurogene Inc. | 16.25 Million USD | -5336.34% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -186.776% |
| AEON Biopharma, Inc. | 278 Thousand USD | -317769.424% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -263684.179% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -826608.516% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -1064.848% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -1346.114% |
| Athira Pharma, Inc. | 1.58 Million USD | -55652.492% |
| Vaccinex, Inc. | 247 Thousand USD | -357663.968% |
| HCW Biologics Inc. | 6.45 Million USD | -13596.645% |
| XOMA Corporation | 124.45 Million USD | -610.066% |
| Nektar Therapeutics | 230.4 Million USD | -283.539% |
| Arvinas, Inc. | 3.4 Million USD | -25890.5% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -54056.001% |
| Merus N.V. | 12.16 Million USD | -7165.886% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -588.072% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -6296.967% |
| Rezolute, Inc. | 2.22 Million USD | -39562.343% |
| Clene Inc. | 32.16 Million USD | -2647.666% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -504705.402% |
| BeyondSpring Inc. | 3.99 Million USD | -22019.574% |
| Synlogic, Inc. | 17.27 Million USD | -5015.352% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -67875.154% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -2524691.429% |
| Peak Bio, Inc. | 10.72 Million USD | -8141.866% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -1601.899% |
| Krystal Biotech, Inc. | 8.09 Million USD | -10817.681% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -399.207% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -12421.992% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -646836.908% |
| MannKind Corporation | 382.37 Million USD | -131.1% |
| Ikena Oncology, Inc. | 10.73 Million USD | -8129.438% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -215957.946% |
| Gossamer Bio, Inc. | 212.46 Million USD | -315.918% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -507760.345% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -9546.076% |
| Legend Biotech Corporation | 328.67 Million USD | -168.863% |
| Mural Oncology plc | 15 Million USD | -5787.647% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -1763.275% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -41959.829% |
| Champions Oncology, Inc. | 7.43 Million USD | -11793.365% |
| REGENXBIO Inc. | 89.29 Million USD | -889.671% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -103290.675% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -159702.127% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -16222.072% |
| Vaxart, Inc. | 26.51 Million USD | -3232.869% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -5543.844% |
| Cellectis S.A. | 92.85 Million USD | -851.695% |
| Longeveron Inc. | 2.04 Million USD | -43196.276% |
| Repare Therapeutics Inc. | 3.41 Million USD | -25814.282% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 36.736% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -1796.628% |
| Revolution Medicines, Inc. | 87.94 Million USD | -904.818% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -510695.954% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -22254.591% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -278662.461% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -504858.286% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | -9.312% |
| Denali Therapeutics Inc. | 52.24 Million USD | -1591.539% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -6034.319% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -64214.192% |
| Cingulate Inc. | 3.13 Million USD | -28086.574% |
| Passage Bio, Inc. | 26.29 Million USD | -3260.755% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -13158.47% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -216487.5% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -98745.302% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -4197.831% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -70033.095% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -35951.953% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -28195.773% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -108861.406% |
| OmniAb, Inc. | 25.56 Million USD | -3357.13% |
| Anew Medical, Inc. | 1.6 Million USD | -54957.757% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -2887.124% |
| Lipocine Inc. | 17.16 Thousand USD | -5147732.926% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -7493.031% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -2451.915% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -14859.678% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -1445.619% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -435208.867% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -17008.945% |
| Ocugen, Inc. | 6.94 Million USD | -12631.264% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -6154.349% |
| Q32 Bio Inc. | 1.31 Million USD | -66946.813% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -131399.554% |
| Alumis Inc. Common Stock | 32.58 Million USD | -2612.33% |
| Equillium, Inc. | 824 Thousand USD | -107142.354% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -9633.197% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -293669.739% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -480.225% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -1628.024% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -113915.777% |
| Dominari Holdings Inc. | 3.02 Million USD | -29083.52% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -935136.593% |
| vTv Therapeutics Inc. | 529 Thousand USD | -166946.692% |
| Bio-Techne Corporation | 419.53 Million USD | -110.631% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -1127.397% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -356.525% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -5132.573% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -3782.247% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -14486.943% |
| Nkarta, Inc. | 88.33 Million USD | -900.325% |
| BioCardia, Inc. | 1.31 Million USD | -67099.772% |
| Iterum Therapeutics plc | 19.5 Million USD | -4429.586% |